So, BTG (now owned by Boston Scientific) have just received full FDA approval for Theraspheres (the old competitor to Sirtex Sirspheres)
The interesting thing for me is that the approval is based on a single arm study (TARGET) of just over 200 patients. It appears to have started about 2 years ago.
I'm posting a few links and ask you to double check:
https://clinicaltrials.gov/ct2/show/NCT03295006
https://www.bostonscientific.com/en-US/medical-specialties/interventional-radiology/interventional-oncology/cancer-therapies-ablation/therasphere/proven-results/target-study.html
https://www.fiercebiotech.com/medtech/boston-scientific-s-recently-approved-radioactive-microspheres-extend-liver-cancer-survival
I guess it raises the possibility that an RCT might not be required for Oncosil.
It also continues a theme of general endorsement for internal radiation therapies in general.
I think this is very positive, and I am looking forward to the FDA's view.
I have changed my sentiment from hold to buy.
- Forums
- ASX - By Stock
- OSL
- Theraspheres and FDA approval
Theraspheres and FDA approval
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
1.1¢ |
Change
-0.001(8.33%) |
Mkt cap ! $41.62M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.1¢ | $2.932K | 266.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 4463993 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 2777394 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 4463993 | 0.011 |
31 | 16247280 | 0.010 |
14 | 7983444 | 0.009 |
8 | 5387500 | 0.008 |
6 | 2714285 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 2777394 | 6 |
0.013 | 11622498 | 7 |
0.014 | 5914139 | 8 |
0.015 | 8743600 | 5 |
0.016 | 3766668 | 2 |
Last trade - 10.06am 06/09/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |